The Antidepressants Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The size of the antidepressants market has been expanding consistently over the years. The market value is predicted to escalate from $17.11 billion in 2024 to $17.82 billion in 2025, with a compound annual growth rate (CAGR) of 4.2%.
By 2029, the antidepressants market is projected to reach a size of $20.25 billion, growing at a compound annual growth rate (CAGR) of 3.2%.
Download Your Free Sample of the 2025 Antidepressants Market Report and Uncover Key Trends Now!The key drivers in the antidepressants market are:
• Increasing mental health awareness and advocacy
• Rising global impact of stress and lifestyle adjustments
• Integration of mental health services and advances in psychiatry research
• Development and availability of telemedicine and remote mental health services
The antidepressants market covered in this report is segmented –
1) By Product: Selective Serotonin Reuptake Inhibitor (SSRI), Serotonin-norepinephrine Reuptake Inhibitor (SNRI), Tricyclic Antidepressant (TCA), Monoamine Oxidase Inhibitor (MAOI)
2) By Drug Class: Monoamine Oxidase Inhibitors, Serotonin Antagonist And Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, Selective Serotonin Reuptake Inhibitors, Tricyclic Antidepressants
3) By Depressive Disorder: Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder
The key trends in the antidepressants market are:
• The rise in mental health awareness and advocacy is shaping the future of the antidepressants market.
• Increasing influence of stress and lifestyle changes globally is an emerging trend.
• The integration of mental health services and advancement in telemedicine is an upcoming trend.
• Focus on side effect profiles and the growth of generic markets are significant trends influencing the future of the market.
Major companies in the antidepressants market are:
• Pfizer Inc.
• Johnson & Johnson Services Inc.
• F. Hoffmann-La Roche Ltd.
• Merck & Co. Inc.
• AbbVie Inc.
• Novartis AG
• Sanofi S.A.
• Bristol Myers Squibb Company
• Fresenius Kabi AG
• Abbott Laboratories
• AstraZeneca plc
• GlaxoSmithKline plc
• Takeda Pharmaceutical Co. Ltd.
• Eli Lilly and Company
• Boehringer Ingelheim GmbH
• H. Lundbeck AS
• Teva Pharmaceutical Industries Ltd.
• Akeda Pharmaceutical Co.
• Otsuka Pharmaceutical Co.
• Mylan N.V
• Sun Pharmaceuticals Pvt. Ltd.
• Servier Laboratories
• Sumitomo Dainippon Pharma Co.
• Aurobindo Pharma Limited
• Dr. Reddy's Laboratories Ltd.
• Hikma Pharmaceuticals plc
• Allergan plc
• Alkermes plc
• Egis Pharmaceuticals plc
• Forest Laboratories Inc.
North America was the largest region in the antidepressants market in 2024